AUNA (AUNA) Q1 2024: Peru EBITDA Margin Surges to 20.4% as High-Complexity Mix Drives Scale

2024-05-20 | By EarningsIQ Research

AUNA’s integrated healthcare platform delivered broad-based revenue and margin gains, with Peru’s segment margin surpassing internal targets on high-complexity services and network optimization. Mexico’s ramp remains methodical, with management emphasizing long-term physician recruitment and asset-light oncology expansion. Consolidated EBITDA growth guidance is reiterated, but operational leverage and capital allocation discipline will be tested as new geographies scale.

Summary

• Peru Margin Inflection: High-complexity services and network referrals drove margin expansion well above target.
• Mexico Scale-Up Pace: Physician recruitment and asset-light oncology rollout remain gradual, with near-term occupancy flat.
• Capital Deployment Focus: Deleveraging and disciplined CapEx remain central as AUNA prioritizes long-term growth over dividends.

Business Overview

AUNA operates a vertically and horizontally integrated healthcare platform across Peru, Mexico, and Colombia, providing hospital services, specialty clinics, and health insurance plans with a focus on oncology and high-complexity care. The company generates revenue through direct healthcare services, insurance memberships (notably OncoSalud, oncology plan business), and B2B insurance partnerships. Its major segments are healthcare services in Peru, Mexico, and Colombia, as well as the OncoSalud health plan business in Peru. Expansion into Mexico leverages the OCA acquisition and the new OncoMexico insurance and oncology initiative.

Performance Analysis

Consolidated revenue grew at a double-digit pace, underpinned by strong performance in Peru and Colombia and early traction in Mexico’s scaling initiatives. Gross margin held firm at 38.5%, with operating leverage most evident in Peru, where adjusted EBITDA rose 40% year-on-year and margin reached 20.4%, exceeding the company’s internal target. Colombia delivered 15% revenue growth, with a shift toward higher-value oncology and specialty care offsetting a reduction in low-complexity patient volume.

Mexico’s revenue rose 6% sequentially, but occupancy remained flat at 41% as physician engagement and calendar effects muted growth. Adjusted EBITDA in Mexico declined year-on-year due to higher SG&A tied to investments in commercial and operational infrastructure, though margins remained robust at 34%. OncoSalud in Peru saw revenues climb 16%, driven by increased plan memberships and higher average revenue per customer, with stable medical loss ratios supporting a 24% EBITDA increase.

• Peru Margin Outperformance: Network optimization and high-complexity mix lifted profitability well above target.
• Colombia Service Mix Shift: Strategic focus on oncology and specialty care drove higher average revenue per patient.
• Mexico Investment Drag: Ramp-up SG&A and flat occupancy weighed on near-term EBITDA, but sequential margin improvement signals early traction.

Adjusted net income reached 22 million soles, reversing prior-year and sequential losses, aided by top-line growth and cost discipline despite non-cash financial charges. Operating cash flow rose modestly, while IPO proceeds were largely deployed to acquire minority interests and support deleveraging.

Executive Commentary

Strategic Positioning

1. High-Complexity Service Mix as Margin Lever

AUNA’s deliberate shift toward high-complexity specialties—oncology, cardiology, neurology, trauma—has driven higher average revenue per patient and enabled significant margin expansion, especially in Peru. This mix optimization is central to the company’s “AUNA way,” which standardizes care pathways and concentrates advanced procedures in core facilities, unlocking operating leverage and predictable financial outcomes.

2. Mexico Ramp-Up: Physician Model and Asset-Light Oncology

Mexico is positioned as the next major growth engine, but progress is paced by physician recruitment and the rollout of OncoMexico, an oncology insurance and services platform designed to scale with low capital intensity. Management’s focus is on attracting high-yield specialists and building referral channels with insurers and brokers, aiming for sustainable, high-complexity volume rather than near-term occupancy gains.

3. Deleveraging and Disciplined Capital Allocation

Following the IPO, AUNA has prioritized deleveraging and prudent CapEx, with over half of debt now in local currency and a stated target of 3x leverage. Dividend payments remain off the table as retained earnings are reinvested into growth initiatives, particularly in Mexico and digital/operational systems upgrades across all markets.

4. Digital and Operational Infrastructure Investment

SAP and hospital information system rollouts in Mexico and Colombia are underway, aiming to unify legacy systems and support scalable, data-driven operations. These investments are expected to enhance efficiency, physician productivity, and patient experience, but represent a near-term drag on SG&A and require careful execution to realize long-term returns.

5. Insurance and B2B Platform Expansion

B2B insurance channels, such as Integra (to be rebranded as AUNA Solución), provide distribution leverage for OncoMexico and deepen payer relationships in Mexico. These platforms are intended to support both direct healthcare delivery and insurance membership growth, reinforcing AUNA’s integrated model.

Key Considerations

This quarter underscores AUNA’s operational discipline and strategic patience, as leadership resists pressure for rapid occupancy gains in favor of building sustainable, high-complexity networks and insurance platforms. The following considerations are central to the company’s trajectory:

• Margin Expansion Through Mix: Peru’s results validate the strategy of concentrating high-value services and optimizing facility utilization.
• Mexico as Long-Term Growth Engine: Physician recruitment and insurance platform buildout are prerequisites for scaling, with management emphasizing multi-year rather than quarterly targets.
• Colombia’s Payment Transition: Direct payments from ADRES, Colombia’s public health fund, are creating short-term working capital volatility but may improve collections over time.
• Capital Allocation Discipline: CapEx is tightly controlled, with $15 million budgeted for 2024 and no near-term dividend plans as deleveraging remains a priority.
• Digital Transformation Risk-Reward: SAP and hospital system upgrades are critical for future scalability but introduce integration risk and near-term cost pressure.

Risks

Key risks include execution delays in Mexico’s physician recruitment and occupancy ramp, integration complexity of new digital systems, and regulatory or payment uncertainty in Colombia’s evolving public health landscape. The company’s margin gains are vulnerable to mix shifts or competitive responses, and capital allocation discipline will be tested as growth ambitions scale across geographies. Currency volatility and extraordinary financial charges, such as derivative mark-to-market impacts, add further unpredictability to reported results.

Forward Outlook

For Q2 2024, AUNA guided to:

• Continued revenue growth across all segments, with margin expansion weighted toward Peru and Colombia.
• Mexico’s operational impact expected to accelerate in the second half as physician recruitment and OncoMexico rollout gain traction.

For full-year 2024, management reaffirmed:

• At least 20% consolidated adjusted EBITDA growth (FX neutral), with the majority of gains expected in the second half.

Management highlighted several factors that will shape results:

• Timing of high-complexity service mix shift and physician onboarding in Mexico.
• Stability of payment flows and working capital in Colombia amid regulatory transitions.

Takeaways

AUNA’s Q1 results showcase the power of its integrated, high-complexity healthcare model, with Peru setting the profitability benchmark and Mexico positioned as the next growth catalyst.

• Margin Leadership in Peru: Network optimization and high-complexity mix have delivered margin outperformance, validating the company’s operational model and providing a template for other geographies.
• Mexico’s Gradual Build: Physician recruitment and insurance platform expansion are progressing, but management is prioritizing quality and predictability over short-term volume, signaling patience and discipline.
• Execution Watchpoints: Investors should monitor Mexico’s occupancy and physician ramp, digital system integration, and working capital trends in Colombia for signs of sustained operational leverage and risk containment.

Conclusion

AUNA’s Q1 demonstrates disciplined execution and strategic clarity, with Peru’s margin surge and Colombia’s service mix shift offsetting Mexico’s measured ramp. The focus remains on scaling high-complexity, integrated care models while maintaining capital allocation discipline and preparing for long-term growth in underpenetrated Latin American markets.

Industry Read-Through

AUNA’s results reinforce the thesis that integrated healthcare platforms with a focus on high-complexity, specialty care can achieve superior margins and defensible growth in emerging markets. The deliberate pace of physician recruitment and asset-light expansion in Mexico highlights the operational challenges and capital discipline required for cross-border healthcare scaling. The shift toward digital infrastructure and B2B insurance channels signals a broader industry pivot toward platform models that blend direct care, insurance, and technology to drive patient retention and financial predictability. Risks around regulatory change and payment collections in public-private healthcare systems remain salient for all regional operators.

AUNA Healthcare Hospitals Latin America Oncology Insurance Deleveraging Digital Transformation